Exit Examinations European view M62 Coloproctolgy course, Huddersfield Lars Påhlman Dept. Surgery, Colorectal unit University Hospital, Uppsala, Sweden.

Slides:



Advertisements
Similar presentations
Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden
Advertisements

What is the most appropriate therapy for a 50 year old patient with T3N+ rectal cancer and isolated surgically resectable liver Metastases? – Systemic.
Neoadjuvant therapy for Rectal cancer
IAEA Quality Audits in Radiotherapy
Cornelis J.H. van de Velde, MD, PhD,FRCPS(hon)FACS(hon) Professor of Surgery President ECCO - the European Cancer Organization Past-President European.
Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
Rectal Cancer: A Complete Clinical Response…Now what?
IAEA International Atomic Energy Agency IAEA quality audits in radiotherapy Joanna Izewska Head, Dosimetry Laboratory Dosimetry & Medical Radiation Physics.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.
Defining the Colorectal Surgeons role in patients with colorectal cancer and limited metastatic disease Jose G. Guillem, MD, MPH Department of Surgery.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;
Lars Påhlman Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden How to handle peritoneal carcinomatosis found at laparotomy.
Dept Surgery, Colorectal unit University Hospital, Uppsala, Sweden
NORCCAG audit report 2011: mortality, survival and reconstructive rectal surgery David W Borowski for the members of the Northern Region Colorectal Cancer.
Feza H. Remzi MD, FACS, FASCRS
INTERNATIONAL CONFERENCE ON ADVANCED TREATMENT OF COLON CANCER Improving treatment of colon cancer. What is essential? JUNE BERGEN, NORWAY.
Preoperative CCRT in Colorectal Cancer 嘉義長庚醫院 大腸直腸外科 葉重宏.
Specialist surgery “Some surgeons perform less than optimal surgery. Some are less competent technically than their colleagues; and some fail to supervise.
Oncological and functional outcome of ultra low colo – anal anastomosis with and without intersphincteric resection for low rectal cancer R.Ruppert Städt.
Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.
What is the Preferable Treatment Option for T1/T2 Low Rectal Cancer? Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology.
1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim,
TEMPORARY FECAL DIVERSION STUDENTS’ SESSION, 10TH ANNUAL ESCP MEETING, DUBLIN ANDERS MARK CHRISTENSEN ON BEHALF OF GROUP 2.
TME trial TME radiotherapy 5 x 5 Gy TME alone randomisation n = 1861 resectable rectal carcinoma if CRM+: 50 GY.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Preoperative chemoradiotherapy and postoperative chemotherapy with 5-FU and oxaliplatin versus 5-FU alone in locally advanced rectal cancer: First results.
Rectal Cancer: French Prodige Study: Best of ASCO, Beirut, July 2009 Prof Eric Van Cutsem, MD, PhD Digestive Oncology Leuven, Belgium.
RT with TME surgery ? OUTLINEOUTLINE. Prostate Seminal vessels Neurovascular bundle Denonvilliers Fascia “holy plane” (Fascia rectalis) Total Mesorectal.
“small” T3 short-term RT and TME “large” T3 long-term CRT and TME T4 long term CRT and TME Therefore: tailored treatment.
Prognosis of colon cancer compared with rectal cancer. Where lies the difference? Bjørn S. Nedrebø Stavanger University Hospital.
* AP: Anteroposterior, Lat: Lateral Tumor diameter, tumor length, depth of penetration, distance from the anal verge, deep and narrow pelvic dimension.
A comparison of open vs laparoscopic emergency colonic surgery; short term results from a district general hospital. D Vijayanand, A Haq, D Roberts, &
Local recurrence after rectal cancer resection is strongly related to the plane of surgical (PoS) dissection and is further reduced by pre-operative short.
Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,
Adjuvant chemotherapy in Rectal Cancer?. What is the evidence for adjuvant chemotherapy? Do patients achieving a pathological complete response need chemotherapy?
Gastric Cancer Resections in BC: How are we doing? Trevor D Hamilton MD FRCSC Surgical Oncology Network November 7, 2015.
Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,
Quality of Life and Functional Results Following Pelvic Exenteration Erin Kennedy September 19, 2015.
J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.
Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.
FDA Meeting June 9, 2010 “User Training” Donald A. Goer, Ph.D. Chief Scientist Intraop medical Corporation.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
Basingstoke Colorectal The Particular Problem of Low Rectal Cancer Brendan Moran Basingstoke 4 th East-West Colorectal Days Hungary 2008.
Colorectal Cancer Screening Implementation of a public health programme An Expert Group on Colorectal Cancer Screening Cancer Society of Finland, Finnish.
How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
RECTAL CARCINOMA AND PREOPERATIVE MRI: USING A NATIONAL DATASET FOR REGIONAL AUDIT South West Cancer Intelligence Service J Weeks
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
PHASE II TRIAL OF HYPOFRACTIONATED BREAST IRRADIATION WITH VMAT-SIB TECHNIQUE: TOXICITY AND EARLY CLINICAL ASSESSMENT IN 270 PATIENTS F. De Rose¹, F. Alongi¹,
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Karcinom rektuma- management
Esophagectomy for cancer:
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative.
National Bowel Cancer Audit
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
What is the most appropriate therapy for a 50 year old patient with T3N+ rectal cancer and isolated resectable liver metastases?
Systemic chemotherapy->chemoradiation->surgery.
Christopher Crane, MD Professor, Dept of Radiation Oncology
PRESENTATOR: MD VƯƠNG NHẤT PHƯƠNG. HO CHI MINH CITY ONCOLOGY HOSPITAL
Effect of Neoadjuvant Concurrent Chemoradiotherapy on Locally Advanced Middle and Low Rectal Cancer— A Propensity Score Matching Study 官泰全,林春吉,楊純豪,姜正愷,林宏鑫,藍苑慈,
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Neoadjuvant Adjuvant Curative Palliative
The role of simultaneous resection of synchronous liver metastasis and primary colorectal cancer Samuel Lo Department of Surgery.
The STAR-TREC Trial SIV Presentation
Seoul National university bundang hospital
Presentation transcript:

Exit Examinations European view M62 Coloproctolgy course, Huddersfield Lars Påhlman Dept. Surgery, Colorectal unit University Hospital, Uppsala, Sweden

Training in colorectal surgery Why so important  Bad results  Changes in treatment  The surgeon is important  Centralisation ?

Training in colorectal surgery What are the goals ?  Accreditation of surgeons  Accreditation of units  Accreditation of training program  Audit (national ?)

Training in colorectal surgery Which tools ?  UEMS - Section of Surgery  Division of different specialities  Coloproctology  EBSQ

Training in colorectal surgery European Board of Surgical Qualification = EBSQ

Training in colorectal surgery Division of Coloproctology  All European countries  2 members / country in the board  President + vice President  Secretary

Training in colorectal surgery EBSQ - Coloproctology  ~ 60 surgeons examined  From all around Europe  What is the value so far ?  Not accepted in many countries

Training in colorectal surgery EBSQ - Coloproctology  Yearly examinations at ESCP  Accreditation of units  ‘National’ examinations  Training program

Training in colorectal surgery National examinations  Lead by a national group with EBSQ - accreditation  Invited examiners from different European countries (EBSQ - accredited)

Training in colorectal surgery National training program The Swedish Rectal Cancer experience

Rectal Cancer in Sweden Bad results ? Until the end of the 80’s most centres had > 30 % local failure rate !

Rectal Cancer in Sweden Changes in treatment (early 80’s)  Radiotherapy !  3 major trials conducted  Centralisation ?

Rectal Cancer in Sweden Radiotherapy  Stockholm-Malmö trial 25 Gy preop. vs surgery alone  Uppsala trial 25 Gy preop. vs 60 Gy postop.  Swedish Rectal Cancer Trial 25 Gy preop. vs surgery alone

Rectal Cancer in Sweden Radiotherapy  Preop. superior to postop.  Local failure rates reduced from  30 % to 15 %  Overall survival benefit

Rectal Cancer in Sweden Centralisation ? In all Swedish trials 50 % of the patients were operated upon by a surgeon doing < 1 rectal cancer per year

Rectal Cancer in Sweden The ‘Heald’ - wave

Rectal Cancer in Sweden Centralisation ! (mid 90’s)  Small hospitals were closed  Workshops in TME - technique  Rectal cancer was not considered a procedure for general surgeons

Quality Assurance in Surgery Swedish Rectal Cancer Register Started 1995 after a long discussion regarding centralisation of rectal cancer surgery

Quality Assurance in Surgery Rectal Cancer ideal  End - points well defined  A common disease  Surgery an important treatment option

Quality Assurance in Surgery Rectal Cancer; end - points  Postop. morbidity and mortality  Sphincter preservation  Local recurrence  Survival  Quality of life

Quality Assurance in Surgery Rectal Cancer; how ?  Meticulous audit  Independent observer  Comparing results with others  Quality register

Swedish Rectal Cancer Register Organisation  Six health-care regions  Oncology centre in each region  All Department of Surgery  One responsible surgeon  Swedish cancer register

Swedish Rectal Cancer Register Organisation  Each region has it’s own register  Regional differences  Local research project  Same “mini - data base”

Swedish Rectal Cancer Register Data collection  Patients reported at discharge  Report to the cancer register by Surgeons and pathologists  The oncology centre in the region checks with the cancer register

Swedish Rectal Cancer Register Data base  Preop. work - out  Treatment (surgery, chemo, irradiation)  Postop. complications  Late complications  Oncological outcome

Swedish Rectal Cancer Register Organisation Follow - up  At minimum every year  Each time something happens  If not reported the Oncology centre sends a reminder

Swedish Rectal Cancer Register Data report Feed - back to surgeons  National report every year  Data divided for each region  Data for the specific surgical department

Swedish Rectal Cancer Register Data report   15,000 patients (  1,500 yearly)  Base - line data  Trends in treatment  5-year oncological data

Swedish Rectal Cancer Register Important data from 1997  Total number 1,414  48 % anterior resections  24 % abdominoperineal resections  35 % overall postop. complications  10 % re-operations within 30 days  8 % local recurrence rate  2.5 % postop. mortality

Survival (all patients) Relative Crude

Relative survival Stage I Stage II

Relative survival Stage III Stage IV

Local recurrence % ( ) All patientsR 0 surgery

Dutch trial - Local recurrence Patients with R 0 (n=1789) 5.8% vs 11.4% p < TME alone RT + TME Resectable rectal cancer !

Quality Assurance in Surgery How to evaluate results ?  Look for changes in trends  Are guide - lines followed ?  Identify ‘bad’ units  Identify ‘bad’ doctors

Irrigation of the rectal stump

Swedish Rectal Cancer Register 5 years follow-up ( ) Local recurrence rate Irrigation Ant. Resection Hartmann Yes 96 / % 8 / % No 44 / % 11 / % Unknown 7 / % 1 / 17 6 % p < n.s.

Dutch trial - Local recurrence rate Level from the anal verge 10.5% vs 11.9% p = cm cm cm

Local recurrence % ( ) cm cm

Quality Assurance in Surgery How to interfere ?  Propose training  Supervise surgery  Introduce a ‘driving - licence’ in rectal cancer surgery

Quality Assurance in Surgery Future  Mandatory to know the results  New generation of patients  Only the best unit will survive  Quality register the only way !

Rectal Cancer in Sweden A tremendous change ! From > 30 % local failure rate at the end of the 80’s in most centres to  8 % in the mid 90’s. Survival improved !

Rectal Cancer A tremendous change ! The same change in treatment policy has been found in Norway with similar training and audit

Adequate surgical resection for rectal cancer: the surgeon’s view Lars Påhlman Dept Surgery, Colorectal unit University Hospital, Uppsala, Sweden

It is dangerous to smoke